Larvol Delta - Effect-of-Hepatic-Impairment-on-the-Pharmacokinetics-and-Safety-of-VIR2218-and-VIR3434

tobevibart (VIR-3434) - Vir Biotech

elebsiran (VIR-2218) - Alnylam, Vir Biotech

http://clinicaltrials.gov/ct2/show/NCT05484206

Sep 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next